Novel 1,3-diarylpyrazole acrylamides: synthesis, antiplatelet activity screening, and in silico evaluation studies
作者:Sultan Nacak Baytas、Nazan Inceler、Yesim Ozkan、Serdar Unlu、M. Fethi Sahin
DOI:10.1007/s00044-013-0580-x
日期:2013.12
(E)-3-[3-(pyridin-4-yl)-1-phenyl-1H-pyrazole-4-yl]acryl amides were evaluated for their antiplatelet activities. Compounds 4o and 4r were found as active derivatives showing a potent inhibitory activity on the arachidonic acid-induced aggregation, with IC50 of 20.2 and 30.3 mu M, respectively. Compounds 4j, 4k, and 4u presented significant inhibitor effect on collagen-induced platelet aggregation (73.1, 82.5, and 86.7 %, respectively). All synthesized compounds demonstrated good drug-likeness and drug-score values in silico evaluations.
(以)−3−[3−(吡啶-4-基团)-1-苯-1H-吡azole-4-yl]丙烯酰胺的抗血栓活性进行了评估。化合物4o和4r被发现为活性化合物,显示出对物-二过氧刺竹酶诱导的聚集有强抑制活性,IC50分别为20.2 μM 和30.3 μM。化合物4j、4k和4u显示出对血小板诱导的胶原诱导的聚集有显著的抑制作用(分别为73.1%、82.5%和86.7%)。所有合成的化合物在虚拟计算中均表现出了良好的药动学性质,且药效分数良好。